What To Expect in Markets This Week: Earnings From Palantir, AMD, McDonald's and More

Investors face a significant week with key earnings reports from tech giants like Palantir, AMD, and Uber, consumer names such as McDonald's and Disney, and major pharmaceutical firms including Novo Nordisk and Eli Lilly, with focus on AI trends, consumer health, and drug sales outlooks. Concurrently, market attention will be on crucial economic data, including the U.S. trade deficit for tariff policy impact, productivity, and consumer credit, alongside speeches from Federal Reserve officials for monetary policy cues after rates were held steady.

Analysis

The market faces a pivotal week with a convergence of major corporate earnings and significant macroeconomic data points. In the technology sector, optimism surrounding artificial intelligence is a key theme, with Palantir (PLTR) trading near record highs and Advanced Micro Devices (AMD) anticipated to demonstrate the competitiveness of its MI350 series chips. Analyst sentiment is also positive for Uber (UBER). This contrasts sharply with divergent signals from the consumer sector, where Disney (DIS) has lifted its full-year profit outlook on streaming growth, while McDonald's (MCD) is experiencing reduced traffic from middle-income households, suggesting lagging consumer confidence. The pharmaceutical industry also presents a cautious outlook, as Novo Nordisk (NVO) lowered its full-year guidance amid declining sales of its weight-loss drugs and Eli Lilly (LLY) cut its profit outlook due to high R&D costs. On the macro front, investors will parse U.S. trade deficit data for insights into tariff impacts and consumer credit data for indications of household financial health. Furthermore, public remarks from several Federal Reserve officials will be scrutinized for future monetary policy direction, particularly after two members voted for an interest rate cut at the last FOMC meeting.

Key Decisions for Investors

• Given the elevated sentiment for AI-related stocks, closely monitor earnings from Palantir and AMD for confirmation of spending trends, as any disappointment could lead to significant revaluations.
• The divergent outlooks for Disney and McDonald's suggest a selective approach to the consumer sector is warranted; MCD's report should be viewed as a key indicator of broader consumer health.
• The negative guidance from Novo Nordisk and Eli Lilly signals potential headwinds for the pharmaceutical industry, prompting a review of exposure to companies facing high R&D costs or sales pressure on key drugs.
• Pay close attention to U.S. trade data and commentary from Fed officials, as shifts in tariff policy or interest rate outlook could override company-specific news and dictate overall market direction.